Immunotoxins constructed with chimeric, short-lived anti-CD22 monoclonal antibodies induce less vascular leak without loss of cytotoxicity.

MAbs
Xiao-yun LiuE S Vitetta

Abstract

An immunotoxin (IT) constructed with RFB4, a murine anti-CD22 monoclonal antibody, and the "deglycosylated" A chain of ricin has shown activity at safe doses in patients with non-Hodgkin lymphoma and in children with acute lymphoblastic leukemia. The dose limiting toxicity is vascular leak syndrome (VLS), which appears to be due to a unique amino acid motif in the ricin toxin A (RTA) chain that damages vascular endothelial cells. We mutated recombinant (r) RTA to disable this site, but await testing of the IT prepared with this mutant RTA in humans. Another possible approach to reducing IT-induced VLS is to shorten the half-life of the IT in vivo. We previously constructed a mouse-human chimeric RFB4 by grafting the variable genes of RFB4 onto the human IgG1k constant regions. Here, we report the expansion of our panel of mutant chimeric RFB4s (mcRFB4s) that lack the ability to bind to the neonatal Fc receptor (FcRn). In comparison with cRFB4, which had a T1/2 of 263 h, the mcRFB4s had T1/2s ranging from 39 to 106 h. ITs were constructed with these mcRFB4s and rRTA. The mcRFB4-RTA ITs retained their cytotoxicity in vitro and had shorter half lives than the parental cRFB4-RTA IT. In addition, the mcRFB4 IT with the shortest T1/2...Continue Reading

References

May 25, 1987·FEBS Letters·M O'HareJ M Lord
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·C B SiegallH P Fell
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T J LynchJ Ritz
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·R BalunaE S Vitetta
Oct 3, 1999·European Journal of Immunology·J K KimE S Ward
Apr 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R J KreitmanI Pastan
Jun 3, 2000·Annual Review of Immunology·V Ghetie, E S Ward
Sep 11, 2001·Multiple Sclerosis : Clinical and Laboratory Research·S J CampD W Langdon
Oct 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·P L TazzariF Stirpe
Mar 11, 2003·Nature Biotechnology·Joan E SmallshawEllen S Vitetta
Dec 31, 2003·The Journal of Biological Chemistry·Paul R HintonNaoya Tsurushita
Jun 23, 2006·Neoplasia : an International Journal for Oncology Research·Yuying LiuMichael G Rosenblum
Jun 24, 2006·The Journal of Biological Chemistry·William F Dall'AcquaHerren Wu
Oct 25, 2006·Annual Review of Medicine·Ira PastanRobert J Kreitman
Feb 4, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ralph F AldersonIra Pastan
Jun 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yik Andy YeungHenry B Lowman
Oct 31, 2009·Journal of Pediatric Hematology/oncology·Larry HerreraJohn Schindler
Aug 6, 2010·Methods in Molecular Biology·Jung Hee WooArthur E Frankel

❮ Previous
Next ❯

Citations

Dec 12, 2012·Current Allergy and Asthma Reports·Sivasubramanian Baskar, Natarajan Muthusamy
Oct 10, 2013·Toxins·Letizia PolitoAndrea Bolognesi
Jun 12, 2012·Expert Opinion on Biological Therapy·Serengulam V Govindan, David M Goldenberg
May 31, 2013·Biotechnology and Bioengineering·Miller TranStephen P Mayfield
Nov 11, 2014·British Journal of Haematology·Jing Ai, Anjali Advani
Mar 1, 2014·Blood·Alan S WayneIra Pastan
Sep 10, 2014·Analytical and Bioanalytical Chemistry·Laura K HmielMichael T Boyne
Jun 21, 2019·Toxins·Natalia Sowa-RogozińskaMonika Słomińska-Wojewódzka
May 26, 2017·Biomedicines·Letizia PolitoMassimo Bortolotti
May 20, 2020·ACS Infectious Diseases·Xiao-Ping LiNilgun E Tumer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.